Daniel S. Peeper

Active 1993–2025

86
Papers
26,682
Citations
59
h-index
83
i10-index

Citations

Citations per year for Daniel S. Peeper1971: 2 citations1993: 2 citations1994: 26 citations1995: 45 citations1996: 49 citations1997: 38 citations1998: 48 citations1999: 44 citations2000: 42 citations2001: 24 citations2002: 28 citations2003: 18 citations2004: 21 citations2005: 46 citations2006: 95 citations2007: 107 citations2008: 138 citations2009: 202 citations2010: 239 citations2011: 214 citations2012: 234 citations2013: 266 citations2014: 267 citations2015: 236 citations2016: 275 citations2017: 292 citations2018: 314 citations2019: 836 citations2020: 1,204 citations2021: 1,475 citations2022: 1,313 citations2023: 1,134 citations2024: 1,629 citations2025: 872 citations2026: 30 citations1972–1992: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,042 citing papers, 25.9% of this breakdownChina: 2,489 citing papers, 16% of this breakdownUnited Kingdom: 980 citing papers, 6.3% of this breakdownGermany: 802 citing papers, 5.2% of this breakdownItaly: 658 citing papers, 4.2% of this breakdownNetherlands: 606 citing papers, 3.9% of this breakdownFrance: 590 citing papers, 3.8% of this breakdownJapan: 500 citing papers, 3.2% of this breakdownAustralia: 490 citing papers, 3.1% of this breakdownSpain: 412 citing papers, 2.6% of this breakdownCanada: 405 citing papers, 2.6% of this breakdownSwitzerland: 311 citing papers, 2% of this breakdown
0%25.9%Other 21.2%

Fields

  • Medicine50.3%
  • Biochemistry, Genetics and Molecular Biology36.2%
  • Immunology and Microbiology8.1%
  • Engineering1.6%
  • Neuroscience1.4%
  • Computer Science0.4%
  • Other2%

Topics

  • Cancer Immunotherapy and Biomarkers6.2%
  • Telomeres, Telomerase, and Senescence4.5%
  • Immunotherapy and Immune Responses3.7%
  • Cancer Cells and Metastasis3%
  • Epigenetics and DNA Methylation2.4%
  • Immune cells in cancer2.4%
  • Other77.8%

Coauthors

All papers

Open in search
  1. The human tumor microbiome is composed of tumor type–specific intracellular bacteria

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Elisa A. Rozeman, Christian U. Blank, Anat Ronai, Ron Shaoul, Amnon Amit, Tatiana Dorfman, Ran Kremer, Zvi R. Cohen, Sagi Harnof, Tali Siegal, Einav Yehuda‐Shnaidman, Einav Nili Gal‐Yam, Hagit Shapira, Nicola Baldini, Morgan G. I. Langille, Alon Ben‐Nun, Bella Kaufman, Aviram Nissan, Talia Golan, Maya Dadiani, Keren Levanon, Jair Bar, Shlomit Yust‐Katz, Iris Barshack, Daniel S. Peeper, Dan J. Raz, Eran Segal, Jennifer A. Wargo, Judith Sandbank, Noam Shental, Ravid Straussman - Science 2020 cited by 2,471

  2. B cells and tertiary lymphoid structures promote immunotherapy response

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christine N. Spencer, Elizabeth M. Burton, Lauren E. Haydu, Alexander J. Lazar, Roberta Zapassodi, Courtney W. Hudgens, Deborah A. Ledesma, SuFey Ong, Michael Bailey, Sarah Warren, Disha Rao, Oscar Krijgsman, Elisa A. Rozeman, Daniel S. Peeper, Christian U. Blank, Ton N. Schumacher, Lisa H. Butterfield, Monika A. Zelazowska, Kevin M. McBride, Raghu Kalluri, James P. Allison, Florent Petitprez, Wolf H. Fridman, Catherine Sautès‐Fridman, Nir Hacohen, Katayoun Rezvani, Padmanee Sharma, Michael T. Tetzlaff, Linghua Wang, Jennifer A. Wargo - Nature 2020 cited by 2,745

  3. Oncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network

    Authors: , , , , , , , , - Cell 2008 cited by 2,071

  4. The essence of senescence: Figure 1.

    Authors: , , , - Genes & Development 2010 cited by 2,014

  5. Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2018 cited by 855

  6. Neoadjuvant immunotherapy with nivolumab and ipilimumab induces major pathological responses in patients with head and neck squamous cell carcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christian U. Blank, Jan Paul de Boer, John B.A.G. Haanen, Charlotte L. Zuur - Nature Communications 2021 cited by 336

  7. Survival and biomarker analyses from the OpACIN-neo and OpACIN neoadjuvant immunotherapy trials in stage III melanoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ton N. Schumacher, Alexander M. Menzies, Georgina V. Long, Christian U. Blank - Nature Medicine 2021 cited by 337

  8. Identification of the optimal combination dosing schedule of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma (OpACIN-neo): a multicentre, phase 2, randomised, controlled trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Winan J. van Houdt, Daniel S. Peeper, Andrew J. Spillane, Johan Hansson, Ton N. Schumacher, Georgina V. Long, Christian U. Blank - The Lancet Oncology 2019 cited by 522

  9. BRAFE600-associated senescence-like cell cycle arrest of human naevi

    Authors: , , , , , , , , , - Nature 2005 cited by 2,114

  10. Senescence-messaging secretome: SMS-ing cellular stress

    Authors: , - Nature reviews. Cancer 2009 cited by 879

  11. Rational Cancer Treatment Combinations: An Urgent Clinical Need

    Authors: , - Molecular Cell 2020 cited by 209

  12. Interrogating open issues in cancer precision medicine with patient-derived xenografts

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Pier Giuseppe Pelicci, Alejandro Piris‐Giménez, Sergio Roman‐Roman, Oscar M. Rueda, Joan Seoane, Violeta Serra, Laura Soucek, Dominique Vanhecke, Alberto Villanueva, Emilie Vinolo, Andrea Bertotti, Livio Trusolino - Nature reviews. Cancer 2017 cited by 665

  13. Preserved genetic diversity in organoids cultured from biopsies of human colorectal cancer metastases

    Authors: , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2015 cited by 487

  14. Augmenting Immunotherapy Impact by Lowering Tumor TNF Cytotoxicity Threshold

    Authors: , , , , , , , , , , , , , , , , , , , , , - Cell 2019 cited by 267

  15. A key role for mitochondrial gatekeeper pyruvate dehydrogenase in oncogene-induced senescence

    Authors: , , , , , , , , , , , - Nature 2013 cited by 639

  16. Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma

    Authors: , , , , , , , , , , , , , , , , , , - Nature Communications 2014 cited by 637

  17. Anti-tumour immunity induces aberrant peptide presentation in melanoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature 2020 cited by 149

  18. Tryptophan depletion results in tryptophan-to-phenylalanine substitutants

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Nature 2022 cited by 135

  19. IFN-γ signature enables selection of neoadjuvant treatment in patients with stage III melanoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - The Journal of Experimental Medicine 2023 cited by 74

  20. Plasticity of Extrachromosomal and Intrachromosomal BRAF Amplifications in Overcoming Targeted Therapy Dosage Challenges

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Thomas G. Graeber - Cancer Discovery 2021 cited by 77

  21. XenofilteR: computational deconvolution of mouse and human reads in tumor xenograft sequence data

    Authors: , , , , , , , , , , , , , , , , - BMC Bioinformatics 2018 cited by 171

  22. Integrative epigenetic taxonomy of primary prostate cancer

    Authors: , , , , , , , , , , , , , , - Nature Communications 2018 cited by 161

  23. Targeting the Senescence-Overriding Cooperative Activity of Structurally Unrelated H3K9 Demethylases in Melanoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Cell 2018 cited by 159

  24. Cooperative Targeting of Immunotherapy-Resistant Melanoma and Lung Cancer by an AXL-Targeting Antibody–Drug Conjugate and Immune Checkpoint Blockade

    Authors: , , , , , , , , , , , , , , , , , , - Cancer Research 2021 cited by 66